Related references
Note: Only part of the references are listed.A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
Paul Warrener et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice
Zhiyong Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR
Fatemeh Nanvazadeh et al.
BURNS (2013)
Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design
Weizao Chen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2
Jacqueline M. Tremblay et al.
INFECTION AND IMMUNITY (2013)
Risk Factors and Outcomes of Bacteremia Caused by Drug-Resistant ESKAPE Pathogens in Solid-Organ Transplant Recipients
Marta Bodro et al.
TRANSPLANTATION (2013)
Association Between Cytotoxic and Invasive Pseudomonas aeruginosa and Clinical Outcomes in Bacterial Keratitis
Durga S. Borkar et al.
JAMA OPHTHALMOLOGY (2013)
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization
Meenu Mishra et al.
CELLULAR MICROBIOLOGY (2012)
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized, double-blind, placebo-controlled trial
Bruno Francois et al.
CRITICAL CARE MEDICINE (2012)
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
Antonio DiGiandomenico et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Dual targeting strategies with bispecific antibodies
Roland E. Kontermann
MABS (2012)
Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa
Helga Mikkelsen et al.
ENVIRONMENTAL MICROBIOLOGY (2011)
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Qin Lu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection
H. Calum et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators
Nazzareno Dimasi et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia
K. W. Garey et al.
JOURNAL OF CHEMOTHERAPY (2008)
Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice
Jennifer M. Scarff et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
Cynthia Ryder et al.
CURRENT OPINION IN MICROBIOLOGY (2007)
Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling
J. Andy Schaber et al.
INFECTION AND IMMUNITY (2007)
Antibiotic interactions that select against resistance
Remy Chait et al.
NATURE (2007)
Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruginosa
Chantal Soscia et al.
JOURNAL OF BACTERIOLOGY (2007)
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections
Antonio DiGiandomenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the Psl polysaccharide in adhesion and maintaining biofilm structure postattachment
Luyan Ma et al.
JOURNAL OF BACTERIOLOGY (2006)
Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes
I Ventre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
PscF is a major component of the Pseudomonas aeruginosa type III secretion needle
A Pastor et al.
FEMS MICROBIOLOGY LETTERS (2005)
Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation
KD Jackson et al.
JOURNAL OF BACTERIOLOGY (2004)
A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa
AL Goodman et al.
DEVELOPMENTAL CELL (2004)
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
H Sato et al.
EMBO JOURNAL (2003)
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
H Feltman et al.
MICROBIOLOGY-SGM (2001)